Skip to main content
. 2019;20(6):1797–1802. doi: 10.31557/APJCP.2019.20.6.1797

Table 3.

Factors Related to Mortality of Colorectal Cancer (Multivariate Analysis)*

Variable Number (%) Median time (Year) 95% CI Crude HR (95% CI) Adj. HR (95% CI) p-value**
Health insurance <0.0001
CSMBS 386 (20.50) 3.29 (2.84-4.40) 1 1
UCS 1,407 (74.72) 1.98 (1.69-2.25) 1.36 (1.18-1.57) 1.37 (1.09-1.72)
SSS 90 (4.78) 2.10 (1.57-5.69) 1.04 (0.78-1.40) 0.78 (0.48-1.29)
Combined Stage <0.0001
Stage I+II 327 (28.19) 11.43 (7.59-NA) 1 1
Stage III+IV 833 (71.81) 1.56 (1.37-1.73) 3.05 (2.51-3.72) 2.50 (2.00-3.12)
Treatment <0.0001
Surgery 1,300 (67.32) 3.42 (2.90-4.17) 1 1
Non-Surgery 631 (32.68) 0.79 (0.62-1.00) 2.09 (1.86-2.34) 1.88 (1.45-2.45)
Histological grading <0.0001
Well 842 (70.34) 3.86 (3.10-4.67) 1 1
Moderately 278 (23.23) 2.55 (2.01-3.22) 1.19 (1.00-1.42) 1.24 (1.00-1.52)
Poorly 77 (6.43) 0.98 (0.45-1.49) 2.33 (1.79-3.04) 1.84 (1.32-2.56)
Tumour site group -
Colon 1,147 (59.40) 2.50 (2.07-2.92) 1 -
Rectum 784 (40.60) 2.01 (1.71-2.35) 1.17 (1.05-1.31) -
Histological type -
Adenocarcinoma 1,452 (75.19) 2.89 (2.53-3.22) 1 -
Non-adenocarcinoma 479 (24.81) 0.86 (0.59-1.16) 1.72 (1.52-1.95) -

*, adjusting for gender and age; **, p-value from partial likelihood ratio test